The New York Times
BREAKING NEWS
An expert panel recommended that the F.D.A. authorize Merck’s Covid pill for high-risk adults, which the agency could do within days.
Tuesday, November 30, 2021 4:58 PM EST
The pill, known as molnupiravir, is the first in a new class of antiviral drugs that could work against a wide range of variants, including Omicron.
Do something positive.